VVOS insider trading
Vivos Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Buys · last 90 days
1 · $3.2M
Most recent buy
2026-07-15
Recent insider filings
| Filed | Insider | Type | Shares | Price | Value |
|---|
| 2026-07-15 | Skaff Michael C 10% owner | Bought | 5,498,660 | $0.58 | $3.2M |
| 2026-04-02 | Skaff Michael C 10% owner | Bought | 1,353,625 | $1.34 | $1.8M |
Most active insider buyers
| Insider | Role | Buys | Total bought |
|---|
| Skaff Michael C | 10% owner | 2 | $5.0M |
See VVOS on the chart
Every insider buy and sell for VVOS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.
Open the browserFree sampleData from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.